Skip to main content
. 2020 Dec 8;11(6):e03012-20. doi: 10.1128/mBio.03012-20

FIG 8.

FIG 8

Activation mutations allow a malF-ftsL fusion to complement ΔftsL in the presence of a ftsW-cytoftsK fusion. Plasmid pKTP103 (Ptac::malF1-37-ftsL58-121-6xhis) was introduced into an ftsL depletion strain (SD439 ftsL::kan/pSD296 [Para::ftsL]) in the presence of a plasmid constitutively expressing a FtsW-FtsKcyto fusion without or with an activation mutation (pND16 [PftsK::ftsW-cytoftsK] or pND16* [PftsK::ftsWM269I-cytoftsK], respectively). The strains were spot tested on plates without arabinose (to deplete WT ftsL) and in the presence of IPTG (to induce malF-ftsL) (with or without the activation mutations [ftsLE88K and ftsLG92D]). The cartoon to the right depicts the activity of the FtsL constructs.